The purpose of this study is to demonstrate efficacy of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) ophthalmic gel compared to Vehicle for the treatment of dry eye.
A 7-day Vehicle pre-randomization (run-in) phase during which all patients will receive 1 drop of Vehicle in each eye twice daily will precede the 21-day treatment phase, for an overall study duration of 28 days.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
427
Inactive ingredients used as a placebo comparator
Mean change from baseline in sodium fluorescein corneal staining score
Time frame: Baseline (Day 7), Up to Day 28
Mean change from baseline in Dry Eye Symptom Questionnaire (OSDI) score
Time frame: Baseline (Day 7), Up to Day 28
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.